ORTHOCELL LIMITED - Announcements

Market Cap $86.97M Add to my watchlist

Healthcare Biotechnology

Orthocell Limited is an Australia-based regenerative medicine company. The Company is... Orthocell Limited is an Australia-based regenerative medicine company. The Company is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes Striate+, Remplir, and OrthoACI. Striate+ is a sterile, resorbable collagen membrane used for guided bone and tissue regeneration in dental applications. Remplir is a collagen scaffold used in peripheral nerve repair. OrthoACI or autologous chondrocyte implantation is used for the treatment of articular cartilage defects in the knee and ankle. OrthoACI uses the patient’s own healthy cartilage cells called chondrocytes to assist the regeneration of damaged cartilage. The Company is engaged in the development of its tendon cell therapy in the United States. Its autologous tendon therapy is an advanced injectable cellular therapy for the treatment of chronic tendon injuries.More

Announcements

Filter Results

All Price Sensitive Only

OCC	Change of Management of OCC Shareholding		26/08/19	227.4KB	Share
OCC	Ceasing to be a substantial holder		26/08/19	64.21KB	Share
OCC	Ceasing to be a substantial holder		26/08/19	55.15KB	Share
OCC	Change of Director's Interest Notice MC		26/08/19	149.6KB	Share
OCC	Director Temporary Leave of Absence		23/08/19	962.1KB	Share
OCC	Change of Director's Interest Notice QXZ		23/08/19	285.92KB	Share
OCC	New Patent for CelGro Platform Technology		22/08/19	206.9KB	Share
OCC	Appendix 3B and Notice Under Section 708A		14/08/19	827.8KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	31/07/19	387.26KB	Share
OCC	Appendix 3B and Notice Under Section 708A		25/07/19	357.39KB	Share
OCC	CelGro Study Validates High Quality Nerve Repair	PRICE SENSITIVE	25/07/19	431.48KB	Share
OCC	*Change of Director's Interest Notice 4**		11/07/19	387.97KB	Share
OCC	Appendix 3B and Notice Under Section 708A		11/07/19	357.43KB	Share
OCC	Appendix 3B and Notice Under Section 708A		01/07/19	360.29KB	Share
OCC	CelGro Accelerates Dental Implant Treatments	PRICE SENSITIVE	19/06/19	250.11KB	Share
OCC	Appendix 3B		13/06/19	815.77KB	Share
OCC	Change in substantial holding MHZ		11/06/19	46.98KB	Share
OCC	Change in substantial holding SRV		07/06/19	156.86KB	Share
OCC	Change in substantial holding MC		07/06/19	76.86KB	Share
OCC	Ceasing to be a substantial holder PA		07/06/19	85.94KB	Share
OCC	Change of Director's Interest Notice x 4		07/06/19	387.52KB	Share
OCC	Placement Completion		06/06/19	141.25KB	Share
OCC	Appendix 3B and Notice Under Section 708A		06/06/19	358.27KB	Share
OCC	Appendix 3B and Notice Under Section 708A		31/05/19	355.03KB	Share
OCC	Orthocell announces successful capital raising	PRICE SENSITIVE	30/05/19	156.85KB	Share
OCC	Trading Halt	PRICE SENSITIVE	28/05/19	369.22KB	Share
OCC	*Change of Director's Interest Notice 4**		24/05/19	388.64KB	Share
OCC	Appendix 3B and Notice Under Section 708A		21/05/19	356.47KB	Share
OCC	Investor Update		21/05/19	2.27MB	Share
OCC	Results of Meeting		20/05/19	150.01KB	Share
OCC	Orthocells Recent Success and Opportunities		20/05/19	434.84KB	Share
OCC	Appendix 3B and Notice Under Section 708A		17/05/19	355.73KB	Share
OCC	Change in substantial holding SRV		17/05/19	120.26KB	Share
OCC	Clarification Regarding AustSuper Shareholder Notice		17/05/19	220.12KB	Share
OCC	Change in substantial holding MC		17/05/19	76.58KB	Share
OCC	Change of Director's Interest Notice MC		17/05/19	195.79KB	Share
OCC	Becoming a substantial holder		16/05/19	114.6KB	Share
OCC	Appendix 3B and Notice Under Section 708A		15/05/19	356.41KB	Share
OCC	First Patients Complete Nerve Regeneration Trial	PRICE SENSITIVE	08/05/19	268.48KB	Share
OCC	Orthocell Submits AUS Regulatory Application for CelGro	PRICE SENSITIVE	01/05/19	255.92KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	30/04/19	312.1KB	Share
OCC	Notice of General Meeting/Proxy Form		18/04/19	1.04MB	Share
OCC	Appendix 3B and Notice Under Section 708A		08/04/19	355.14KB	Share
OCC	Orthocells Ortho-ATI Shoulder Tendon Study on Track		06/03/19	477.14KB	Share
OCC	Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/19	2.01MB	Share
OCC	Ceasing to be a substantial holder QXZ		15/02/19	660.31KB	Share
OCC	Orthocells Ortho-ATI shows 82% success rate	PRICE SENSITIVE	13/02/19	249.11KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	31/01/19	232.39KB	Share
OCC	Appendix 3B and Notice Under Section 708A		31/12/18	356.89KB	Share
OCC	Appendix 3B and Notice Under Section 708A		18/12/18	356.86KB	Share
OCC	Placement Completion		18/12/18	139.35KB	Share
OCC	CelGro Approved in Key UK Public Dental Hospital	PRICE SENSITIVE	11/12/18	154.59KB	Share
OCC	Share Placement Successfully Raises $1.8m	PRICE SENSITIVE	11/12/18	151.3KB	Share
OCC	Trading Halt	PRICE SENSITIVE	07/12/18	559.8KB	Share
OCC	Patient Treatment Completed in Dental Implant Study	PRICE SENSITIVE	28/11/18	155.98KB	Share
OCC	Results of Meeting		19/11/18	189.77KB	Share
OCC	OCC Receives New Patents for Celgro Platform Technology	PRICE SENSITIVE	02/11/18	175.23KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	31/10/18	327.11KB	Share
OCC	Investor Update	PRICE SENSITIVE	31/10/18	2.08MB	Share
OCC	Orthocell Secures CelGro Patent Protection in Japan	PRICE SENSITIVE	23/10/18	199.29KB	Share
OCC	Notice of Annual General Meeting/Proxy Form		19/10/18	967.86KB	Share
OCC	Successful CelGro Results Presented at Key Euro Conference	PRICE SENSITIVE	18/10/18	197.36KB	Share
OCC	Appendix 4G		17/10/18	181.59KB	Share
OCC	Annual Report to shareholders		17/10/18	5.26MB	Share
OCC	Orthocell Receives A$2.5m R&D tax Incentive Refund	PRICE SENSITIVE	11/10/18	118.86KB	Share
OCC	CelGro Used as Artificial Periosteum Repairs Bone	PRICE SENSITIVE	04/10/18	172.92KB	Share
OCC	Appendix 3B		04/10/18	345.41KB	Share
OCC	CelGro used in Nano Medicine Breakthrough	PRICE SENSITIVE	27/09/18	498.63KB	Share
OCC	Preliminary Final Report and Annual Financial Statements	PRICE SENSITIVE	31/08/18	3.46MB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	31/07/18	237.89KB	Share
OCC	OCC Reports First Product Use and Sales of CelGro in Ireland	PRICE SENSITIVE	26/07/18	157.63KB	Share
OCC	CelGro Pre-Submission Meeting Completed with the FDA	PRICE SENSITIVE	24/07/18	137.85KB	Share
OCC	Orthocell Receives New Patent for Celgro Platform Technology	PRICE SENSITIVE	20/07/18	136.94KB	Share
OCC	OCC Reports First Product Use and Sales of Celgro in Italy	PRICE SENSITIVE	17/07/18	137.17KB	Share
OCC	Orthocell Appoints Exclusive Distributor in the UK	PRICE SENSITIVE	10/07/18	291.59KB	Share
OCC	New CelGro Arthroscopic Tendon Regeneration Study Commences	PRICE SENSITIVE	02/07/18	145.08KB	Share
OCC	Dr. Jonathan Bell Appointed to Orthocell Advisory Board		25/06/18	143.44KB	Share
OCC	Orthocell Announces Successful Ortho-ATI Study Results	PRICE SENSITIVE	14/06/18	340.09KB	Share
OCC	Orthocell Announces Successful Tendon Study Results	PRICE SENSITIVE	06/06/18	279.45KB	Share
OCC	First Product Use and Sales of CelGro in Poland	PRICE SENSITIVE	31/05/18	145.84KB	Share
OCC	Orthocell Secures CelGro Patent Protection in Europe	PRICE SENSITIVE	24/05/18	160.91KB	Share
OCC	First Product Use and Sale of CelGro in Europe	PRICE SENSITIVE	22/05/18	167.05KB	Share
OCC	10th Patient Treatment Milestone in Human Tendon Study	PRICE SENSITIVE	17/05/18	149.26KB	Share
OCC	*Change of Director's Interest Notice 5**		11/05/18	128.54KB	Share
OCC	Appendix 3B and Notice Under Section 708A		10/05/18	159.27KB	Share
OCC	Orthocell Extends Distributor Network in the EU	PRICE SENSITIVE	08/05/18	166.42KB	Share
OCC	Results of Meeting		07/05/18	135.77KB	Share
OCC	Orthocell Announces Successful Bone Repair Study Results	PRICE SENSITIVE	01/05/18	260.69KB	Share
OCC	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/18	209.92KB	Share
OCC	Orthocell Appoints First Distributor in the EU	PRICE SENSITIVE	30/04/18	149.47KB	Share
OCC	Updated Investor Presentation		16/04/18	1.53MB	Share
OCC	Investor Update		09/04/18	877.21KB	Share
OCC	Notice of General Meeting/Proxy Form		06/04/18	864.05KB	Share
OCC	Cedrus Investments Initiation of Coverage		04/04/18	154.58KB	Share
OCC	Prof. Giuseppe Luongo Appointed to Orthocell Advisory Board		26/03/18	139.25KB	Share
OCC	NDF Research Initiation of Coverage		20/03/18	386.68KB	Share
OCC	Prof. Massimo Simion Appointed to Orthocell Advisory Board		19/03/18	407.55KB	Share
OCC	FDA Publication Supports Regenerative Medicine Acceleration		15/03/18	138.95KB	Share
OCC	Half Yearly Report and Accounts	PRICE SENSITIVE	23/02/18	1.02MB	Share
OCC	New Cell Factory Patent Granted in the US	PRICE SENSITIVE	22/02/18	117.22KB	Share

OCC Change of Management of OCC Shareholding
26/08/19		227.4KB	Share
OCC Ceasing to be a substantial holder
26/08/19		64.21KB	Share
OCC Ceasing to be a substantial holder
26/08/19		55.15KB	Share
OCC Change of Director's Interest Notice MC
26/08/19		149.6KB	Share
OCC Director Temporary Leave of Absence
23/08/19		962.1KB	Share
OCC Change of Director's Interest Notice QXZ
23/08/19		285.92KB	Share
OCC New Patent for CelGro Platform Technology
22/08/19		206.9KB	Share
OCC Appendix 3B and Notice Under Section 708A
14/08/19		827.8KB	Share
OCC Appendix 4C - Quarterly
31/07/19	PRICE SENSITIVE	387.26KB	Share
OCC Appendix 3B and Notice Under Section 708A
25/07/19		357.39KB	Share
OCC CelGro Study Validates High Quality Nerve Repair
25/07/19	PRICE SENSITIVE	431.48KB	Share
OCC *Change of Director's Interest Notice 4**
11/07/19		387.97KB	Share
OCC Appendix 3B and Notice Under Section 708A
11/07/19		357.43KB	Share
OCC Appendix 3B and Notice Under Section 708A
01/07/19		360.29KB	Share
OCC CelGro Accelerates Dental Implant Treatments
19/06/19	PRICE SENSITIVE	250.11KB	Share
OCC Appendix 3B
13/06/19		815.77KB	Share
OCC Change in substantial holding MHZ
11/06/19		46.98KB	Share
OCC Change in substantial holding SRV
07/06/19		156.86KB	Share
OCC Change in substantial holding MC
07/06/19		76.86KB	Share
OCC Ceasing to be a substantial holder PA
07/06/19		85.94KB	Share
OCC Change of Director's Interest Notice x 4
07/06/19		387.52KB	Share
OCC Placement Completion
06/06/19		141.25KB	Share
OCC Appendix 3B and Notice Under Section 708A
06/06/19		358.27KB	Share
OCC Appendix 3B and Notice Under Section 708A
31/05/19		355.03KB	Share
OCC Orthocell announces successful capital raising
30/05/19	PRICE SENSITIVE	156.85KB	Share
OCC Trading Halt
28/05/19	PRICE SENSITIVE	369.22KB	Share
OCC *Change of Director's Interest Notice 4**
24/05/19		388.64KB	Share
OCC Appendix 3B and Notice Under Section 708A
21/05/19		356.47KB	Share
OCC Investor Update
21/05/19		2.27MB	Share
OCC Results of Meeting
20/05/19		150.01KB	Share
OCC Orthocells Recent Success and Opportunities
20/05/19		434.84KB	Share
OCC Appendix 3B and Notice Under Section 708A
17/05/19		355.73KB	Share
OCC Change in substantial holding SRV
17/05/19		120.26KB	Share
OCC Clarification Regarding AustSuper Shareholder Notice
17/05/19		220.12KB	Share
OCC Change in substantial holding MC
17/05/19		76.58KB	Share
OCC Change of Director's Interest Notice MC
17/05/19		195.79KB	Share
OCC Becoming a substantial holder
16/05/19		114.6KB	Share
OCC Appendix 3B and Notice Under Section 708A
15/05/19		356.41KB	Share
OCC First Patients Complete Nerve Regeneration Trial
08/05/19	PRICE SENSITIVE	268.48KB	Share
OCC Orthocell Submits AUS Regulatory Application for CelGro
01/05/19	PRICE SENSITIVE	255.92KB	Share
OCC Appendix 4C - Quarterly
30/04/19	PRICE SENSITIVE	312.1KB	Share
OCC Notice of General Meeting/Proxy Form
18/04/19		1.04MB	Share
OCC Appendix 3B and Notice Under Section 708A
08/04/19		355.14KB	Share
OCC Orthocells Ortho-ATI Shoulder Tendon Study on Track
06/03/19		477.14KB	Share
OCC Half Yearly Report and Accounts
27/02/19	PRICE SENSITIVE	2.01MB	Share
OCC Ceasing to be a substantial holder QXZ
15/02/19		660.31KB	Share
OCC Orthocells Ortho-ATI shows 82% success rate
13/02/19	PRICE SENSITIVE	249.11KB	Share
OCC Appendix 4C - Quarterly
31/01/19	PRICE SENSITIVE	232.39KB	Share
OCC Appendix 3B and Notice Under Section 708A
31/12/18		356.89KB	Share
OCC Appendix 3B and Notice Under Section 708A
18/12/18		356.86KB	Share
OCC Placement Completion
18/12/18		139.35KB	Share
OCC CelGro Approved in Key UK Public Dental Hospital
11/12/18	PRICE SENSITIVE	154.59KB	Share
OCC Share Placement Successfully Raises $1.8m
11/12/18	PRICE SENSITIVE	151.3KB	Share
OCC Trading Halt
07/12/18	PRICE SENSITIVE	559.8KB	Share
OCC Patient Treatment Completed in Dental Implant Study
28/11/18	PRICE SENSITIVE	155.98KB	Share
OCC Results of Meeting
19/11/18		189.77KB	Share
OCC OCC Receives New Patents for Celgro Platform Technology
02/11/18	PRICE SENSITIVE	175.23KB	Share
OCC Appendix 4C - Quarterly
31/10/18	PRICE SENSITIVE	327.11KB	Share
OCC Investor Update
31/10/18	PRICE SENSITIVE	2.08MB	Share
OCC Orthocell Secures CelGro Patent Protection in Japan
23/10/18	PRICE SENSITIVE	199.29KB	Share
OCC Notice of Annual General Meeting/Proxy Form
19/10/18		967.86KB	Share
OCC Successful CelGro Results Presented at Key Euro Conference
18/10/18	PRICE SENSITIVE	197.36KB	Share
OCC Appendix 4G
17/10/18		181.59KB	Share
OCC Annual Report to shareholders
17/10/18		5.26MB	Share
OCC Orthocell Receives A$2.5m R&D tax Incentive Refund
11/10/18	PRICE SENSITIVE	118.86KB	Share
OCC CelGro Used as Artificial Periosteum Repairs Bone
04/10/18	PRICE SENSITIVE	172.92KB	Share
OCC Appendix 3B
04/10/18		345.41KB	Share
OCC CelGro used in Nano Medicine Breakthrough
27/09/18	PRICE SENSITIVE	498.63KB	Share
OCC Preliminary Final Report and Annual Financial Statements
31/08/18	PRICE SENSITIVE	3.46MB	Share
OCC Appendix 4C - Quarterly
31/07/18	PRICE SENSITIVE	237.89KB	Share
OCC OCC Reports First Product Use and Sales of CelGro in Ireland
26/07/18	PRICE SENSITIVE	157.63KB	Share
OCC CelGro Pre-Submission Meeting Completed with the FDA
24/07/18	PRICE SENSITIVE	137.85KB	Share
OCC Orthocell Receives New Patent for Celgro Platform Technology
20/07/18	PRICE SENSITIVE	136.94KB	Share
OCC OCC Reports First Product Use and Sales of Celgro in Italy
17/07/18	PRICE SENSITIVE	137.17KB	Share
OCC Orthocell Appoints Exclusive Distributor in the UK
10/07/18	PRICE SENSITIVE	291.59KB	Share
OCC New CelGro Arthroscopic Tendon Regeneration Study Commences
02/07/18	PRICE SENSITIVE	145.08KB	Share
OCC Dr. Jonathan Bell Appointed to Orthocell Advisory Board
25/06/18		143.44KB	Share
OCC Orthocell Announces Successful Ortho-ATI Study Results
14/06/18	PRICE SENSITIVE	340.09KB	Share
OCC Orthocell Announces Successful Tendon Study Results
06/06/18	PRICE SENSITIVE	279.45KB	Share
OCC First Product Use and Sales of CelGro in Poland
31/05/18	PRICE SENSITIVE	145.84KB	Share
OCC Orthocell Secures CelGro Patent Protection in Europe
24/05/18	PRICE SENSITIVE	160.91KB	Share
OCC First Product Use and Sale of CelGro in Europe
22/05/18	PRICE SENSITIVE	167.05KB	Share
OCC 10th Patient Treatment Milestone in Human Tendon Study
17/05/18	PRICE SENSITIVE	149.26KB	Share
OCC *Change of Director's Interest Notice 5**
11/05/18		128.54KB	Share
OCC Appendix 3B and Notice Under Section 708A
10/05/18		159.27KB	Share
OCC Orthocell Extends Distributor Network in the EU
08/05/18	PRICE SENSITIVE	166.42KB	Share
OCC Results of Meeting
07/05/18		135.77KB	Share
OCC Orthocell Announces Successful Bone Repair Study Results
01/05/18	PRICE SENSITIVE	260.69KB	Share
OCC Appendix 4C - quarterly
30/04/18	PRICE SENSITIVE	209.92KB	Share
OCC Orthocell Appoints First Distributor in the EU
30/04/18	PRICE SENSITIVE	149.47KB	Share
OCC Updated Investor Presentation
16/04/18		1.53MB	Share
OCC Investor Update
09/04/18		877.21KB	Share
OCC Notice of General Meeting/Proxy Form
06/04/18		864.05KB	Share
OCC Cedrus Investments Initiation of Coverage
04/04/18		154.58KB	Share
OCC Prof. Giuseppe Luongo Appointed to Orthocell Advisory Board
26/03/18		139.25KB	Share
OCC NDF Research Initiation of Coverage
20/03/18		386.68KB	Share
OCC Prof. Massimo Simion Appointed to Orthocell Advisory Board
19/03/18		407.55KB	Share
OCC FDA Publication Supports Regenerative Medicine Acceleration
15/03/18		138.95KB	Share
OCC Half Yearly Report and Accounts
23/02/18	PRICE SENSITIVE	1.02MB	Share
OCC New Cell Factory Patent Granted in the US
22/02/18	PRICE SENSITIVE	117.22KB	Share

REFRESH

First 2 3 4 5 6

(20min delay)
Last 41.5¢		Change -0.010(2.35%)		Mkt cap ! $86.97M

Open	High	Low	Value	Volume
42.0¢	42.5¢	41.5¢	$36.29K	86.40K

Buyers (Bids)

No.	Vol.	Price($)
3	11096	41.5¢

Sellers (Offers)

Price($)	Vol.	No.
42.0¢	26292	2

View Market Depth

No.	Vol.	Price($)
3	13696	0.415
6	27374	0.410
2	26293	0.405
7	82300	0.400
2	3291	0.395

Price($)	Vol.	No.
0.415	6700	1
0.420	26292	2
0.430	26556	3
0.435	65000	2
0.440	36400	2

Last trade - 15.55pm 01/10/2024 (20 minute delay)


Last 41.5¢		Change -0.010 ( 2.35 %)
Open	High	Low	Volume
42.0¢	42.0¢	41.5¢	16678
Last updated 15.00pm 01/10/2024 ?

OCC (ASX) Chart

ORTHOCELL LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories